Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Payton, Kendsersky"'
Publikováno v:
US Cardiology Review, Vol 18, Iss , Pp - (2024)
Transcatheter aortic valve replacement (TAVR) has revolutionized the management of aortic valve disease. However, its success has brought attention to concurrent tricuspid valve disease and the inadequacy of treatments. This review explores the emerg
Externí odkaz:
https://doaj.org/article/a4343f40194b4e5c93bc122953e1a235
Autor:
Ryan R. Keane, MD, Anthony P. Carnicelli, MD, Daniel B. Loriaux, MD, Payton Kendsersky, MD, Richard A. Krasuski, MD, Kelly M. Brown, BSN, Kelly Arps, MD, Vivian Baird-Zars, MPH, Jeffrey A. Dixson, MD, Emily Echols, Christopher B. Granger, MD, Robert W. Harrison, MD, Michael Kontos, MD, L. Kristin Newby, MD, MHS, Jeong-Gun Park, PhD, Kevin S. Shah, MD, Bradley W. Ternus, MD, Sean Van Diepen, MD, Jason N. Katz, MD, MHS, David A. Morrow, MD, MPH
Publikováno v:
JACC: Advances, Vol 3, Iss 8, Pp 101077- (2024)
Background: Little is known regarding the characteristics, treatment patterns, and outcomes in patients with adult congenital heart disease (ACHD) admitted to cardiac intensive care units (CICUs). Objectives: The authors sought to better define the c
Externí odkaz:
https://doaj.org/article/9474f3dacc684e14afffae8bb9651e71
Autor:
Anthony P. Carnicelli, Ryan Keane, Kelly M. Brown, Daniel B. Loriaux, Payton Kendsersky, Carlos L. Alviar, Kelly Arps, David D. Berg, erin A. Bohula May, James A. Burke, Jeffrey A. Dixson, Daniel A. Gerber, Michael J. Goldfarb, Christopher B. Granger, Jianping Guo, Robert W. Harrison, Michael Kontos, Patrick R. Lawler, P. Elliott Miller, Jose Nativi-Nicolau, L. Kristin Newby, Lekha Racharla, Robert O. Roswell, Kevin S. Shah, Shashank S. Sinha, Michael A. Solomon, Jeffrey Teuteberg, Graham Wong, Sean van Diepen, Jason N. Katz, David A. Morrow
Publikováno v:
Resuscitation. 183:109664
Cardiac arrest (CA) is a common reason for admission to the cardiac intensive care unit (CICU), though the relative burden of morbidity, mortality, and resource use between admissions with in-hospital (IH) and out-of-hospital (OH) CA is unknown. We c
Autor:
Amir, Kazerouninia, Justin, Georgekutty, Payton, Kendsersky, Ryan D, Byrne, Brendan, Seto, Patricia Y, Chu, Yunfei, Wang, Fred H, Rodriguez, Clayton, Smith, Anita, Saraf, Michael S, Lloyd, Benjamin P, Frischhertz, Dhaval R, Parekh, Peter R, Ermis, Wayne J, Franklin, Wilson W, Lam
Publikováno v:
Cardiovascular drugs and therapy.
Direct oral anticoagulants (DOACs) are not recommended in adult Fontan patients (Level of Evidence C). We hypothesized that DOACs are comparable to warfarin and do not increase thrombotic and embolic complications (TEs) or clinically significant blee
Autor:
John DeStefano, Payton Kendsersky, Molly Silkowski, Emily Ramsayer, Megan Minchak, Matthew Evans, William Mostertz, Arasi Maran, Christopher Nielsen, Valerian Fernandes
Publikováno v:
Journal of the American College of Cardiology. 80:B141
Autor:
David A. Morrow, Jianping Guo, Sean van Diepen, Jeffrey A Dixson, L. Kristin Newby, Anthony P. Carnicelli, Erin A. Bohula, Robert W. Harrison, Ryan Keane, Payton Kendsersky, David D. Berg, Kelly Arps, Kelly Brown, Christopher B. Granger, Jason N. Katz
Publikováno v:
Circulation. 142
Background: Cardiac arrest (CA) is a common reason for cardiac intensive care unit (CICU) admission and is associated with considerable morbidity, mortality, and resource use. Aim: To describe characteristics and outcomes of pts presenting to contemp
Autor:
Cary C Ward, Payton Kendsersky
Publikováno v:
Cardiology clinics. 38(2)
Survivorship into adulthood of patients with congenital heart disease is due to improvements in prenatal detection, novel surgeries, and specialized adult congenital heart disease care. As patients survive further into adulthood, long-term complicati
Autor:
Amir Kazerouninia, Payton Kendsersky, Ryan Byrne, Patricia Chu, Yunfei Wang, Justin Georgekutty, Fred H Rodriguez, Benjamin Frischhertz, Dhaval Parekh, Peter Ermis, Wayne J Franklin, Wilson Lam
Publikováno v:
Circulation. 138
Introduction: Adult Fontan patients are typically prescribed antiplatelet or anticoagulant therapy to manage increased risk for thrombotic and embolic complications (TECs). There is a Class III recommendation against the use of novel oral anticoagula
Publikováno v:
Clinical Trials Week; 10/7/2024, p2624-2624, 1p
Autor:
Kazerouninia, Amir, Georgekutty, Justin, Kendsersky, Payton, Byrne, Ryan D., Seto, Brendan, Chu, Patricia Y., Wang, Yunfei, Rodriguez III, Fred H., Smith, Clayton, Saraf, Anita, Lloyd, Michael S., Frischhertz, Benjamin P., Parekh, Dhaval R., Ermis, Peter R., Franklin, Wayne J., Lam, Wilson W.
Publikováno v:
Cardiovascular Drugs & Therapy; Jun2023, Vol. 37 Issue 3, p519-527, 9p